Skip to main content
. 2019 May 3;2:166. doi: 10.1038/s42003-019-0397-3

Fig. 10.

Fig. 10

Proguanil and tBuPG show micromolar anti-P. berghei-Luciferase liver stage activity. Activity of proguanil and tBuPG was tested in HepG2-A16-CD81EGFP cells infected with P. berghei-Luciferase sporozoites. Data was normalised against atovaquone (ATV) and DMSO, and liver stage P. berghei-Luciferase IC50 values were determined using the average normalised bioluminescence intensity of 8 wells per concentration from two technical replicates of 1536- well plates, and a nonlinear variable slope four-parameter regression curve fitting model in Prism 6 (GraphPad Software Inc.). Proguanil (IC50 6.02 µM) and tBuPG (IC50 2.94 µM)